Digital Pathology Market 2020 Global Trend, Segmentation and Opportunities - Forecast to 2023

Digital Pathology Market Size Research Report, by Type (Human Pathology, Animal Pathology), Product (Hardware, Software), Application (Disease Diagnosis, Mhealth, Drug Discovery) and End-Users (Hospitals, Diagnostic Centers) – Global Forecast Till 2023

Rapid Adoption Of Advanced Technology To Propel The Growth Of The Global Digital Pathology Market

Market Research Future (MRFR) has published a report stating that the Global Digital Pathology Market Size is marked to expand at a remarkable CAGR of 13.04% during the forecast period of 2017-2023 and reach the valuation of USD 8,305.6 Mn by the end of the assessment period. Increased adoption of technologically advanced solutions to optimize the disease diagnosis process in order to provide accurate and faster results are majorly propelling the growth of the global digital pathology market. High prevalence of chronic diseases and increased healthcare expenditure are some other factors that are contributing to the growth of the global digital pathology market. However, low penetration of advanced technology and absence of primary healthcare services are likely to act as restraining factors on the expansion of the global digital pathology market.

Key Players:

The major players profiled by MRFR that are operating in the global Digital Pathology Market are Koninklijke Philips N.V., Danaher Corporation (Leica Biosystems GmbH), Definiens, Huron Digital Pathology Inc and others 

Market Segmentation:

The global digital pathology market is segmented on the basis of type, product, application, and end-users. Based on type, the global digital pathology market is segmented into human pathology and animal pathology. The human pathology segment commands for the major share of 65% in the global digital pathology market due to the high prevalence of chronic diseases among humans. This segment is projected to reach the valuation of USD 5,475.4 Mn by the end of 2023. Based on product, the global digital pathology market has been segmented into hardware, software, and storage. The hardware segment commands for the maximum share of the global digital pathology market and is anticipated to reach the valuation of USD 6,031.9 Mn by the end of 2023.

Based on application, the global digital pathology market is segmented into disease diagnosis, Mhealth, drug discovery, and telemedicine. The disease diagnosis segment is leading the global digital pathology market with the valuation of USD 2,650 Mn by the end of the forecast period. Based on end-users, the global digital pathology market has been segmented into hospital & clinic, diagnostic centers, and research centers & academic institutes. The research centers and academic institutes segment is expanding at the fastest growth rate in the global digital pathology market and is anticipated to reach the valuation of USD 3,778.4 Mn by the end of the assessment period.

Browse More Information @ https://www.marketresearchfuture.com/reports/digital-pathology-market-1955 

Regional Analysis:

Geographically, the global digital pathology market is segmented into four major regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas has emerged as a leading region in the global digital pathology market owing to the increased adoption of technologically advanced solutions in the healthcare sector for accurate and faster diagnosis, high prevalence of chronic diseases and increased healthcare expenditure by the population in this region. Presence of large number of major players and increased research and development for the introduction of advanced diagnostic techniques in the well-developed healthcare sector are fueling the growth of the global digital pathology market in the Europe region. The Asia Pacific region is expanding at the highest CAGR of 13.53% during the assessment period owing to the increasing healthcare expenditure and rapid development of healthcare sector in the emerging economies of this region. Lack of awareness and absence of primary healthcare facilities are resulting in the poor growth of the digital pathology market in the Middle East and Africa region.